IPNews® – Allergan, Inc. was granted partial summary judgment against Cosmetic Alchemy, LLC for inducing its customers to infringe Allergan’s patents that cover its popular eyelash growth drug Latisse.

U.S. District Judge James V. Selna of the Central District of California ruled that Cosmetic Alchemy had induced its customers to infringe Allergan’s patent by marketing and selling its products as a cosmetic that would induce hair growth and instructing its customers to apply the product using Allergan’s patented methods.

To continue reading, click: Allergan Wins Partial Summary Judgment on Latisse Patent Infringement Lawsuit